Shaker Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.25M Buy
39,501
+1,037
+3% +$140K 2.25% 10
2026
Q1
$4.91M Buy
38,464
+18,936
+97% +$2.36M 2.24% 12
2025
Q4
$2.38M Buy
+19,528
New +$2.24M 0.99% 29
2025
Q2
Sell
-5,571
Closed -$452K 117
2025
Q1
$452K Sell
5,571
-4,075
-42% -$364K 0.22% 75
2024
Q4
$869K Buy
9,646
+71
+0.7% +$6.88K 0.36% 61
2024
Q3
$946K Buy
9,575
+3,720
+64% +$365K 0.39% 66
2024
Q2
$543K Buy
+5,855
New +$525K 0.24% 80
2023
Q4
Sell
-15,724
Closed -$1.15M 92
2023
Q3
$1.15M Sell
15,724
-28
-0.2% -$2.24K 0.63% 53
2023
Q2
$1.31M Buy
15,752
+205
+1% +$17.1K 0.67% 51
2023
Q1
$1.18M Buy
15,547
+7,402
+91% +$614K 0.66% 49
2022
Q4
$676K Buy
8,145
+2,710
+50% +$219K 0.42% 60
2022
Q3
$431K Buy
+5,435
New +$458K 0.29% 69
2022
Q2
Sell
-3,031
Closed -$272K 98
2022
Q1
$272K Sell
3,031
-2,986
-50% -$276K 0.14% 87
2021
Q4
$674K Buy
6,017
+27
+0.5% +$3.26K 0.29% 73
2021
Q3
$753K Buy
5,990
+23
+0.4% +$2.96K 0.33% 70
2021
Q2
$808K Sell
5,967
-2,123
-26% -$279K 0.37% 65
2021
Q1
$1.1M Sell
8,090
-2,475
-23% -$371K 0.53% 56
2020
Q4
$1.49M Buy
+10,565
New +$1.35M 0.75% 40

Other funds holding XBI

Shaker Investments's XBI Position: Q2 2026 in Review

Shaker Investments increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.7% in Q2 2026, buying an estimated $140K and bringing the position to 39,501 shares worth $6.25M. The position accounts for 2.25% of the portfolio, ranked #10.

Shaker Investments first reported a position in XBI in Q4 2020 and has held it in 18 quarters since. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Shaker Investments held 39,501 shares of State Street SPDR S&P Biotech ETF worth $6.25M as of Q2 2026.
  • Shaker Investments bought 1,037 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $140K.
  • State Street SPDR S&P Biotech ETF made up 2.25% of Shaker Investments's portfolio in Q2 2026, its #10 holding.
  • Shaker Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 18 quarters since.
  • 260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Shaker Investments's 13F filing for Q2 2026, filed 15 Jul 2026.